HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

H Sahara Selected Research

sulfoquinovosylacylglycerol

1/2005Treatment with beta-SQAG9 prevents rat hepatic ischemia-reperfusion injury.
9/2004Synthetic sulfonolipids deduced from sulfonoquinovosyl diacylglycerols of sea urchin reduces hepatic ischemia-reperfusion injury in rats.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


H Sahara Research Topics

Disease

6Neoplasms (Cancer)
09/2011 - 01/2000
3Adenocarcinoma of Lung
09/2016 - 03/2001
3Reperfusion Injury
05/2016 - 09/2004
2Ischemia
01/2005 - 09/2004
2Ocular Paraneoplastic Syndromes
03/2001 - 02/2001
2Signet Ring Cell Carcinoma
06/2000 - 01/2000
2Stomach Neoplasms (Stomach Cancer)
06/2000 - 01/2000
2Melanoma (Melanoma, Malignant)
06/2000 - 01/2000
1Acidosis
05/2016
1Graft vs Host Disease (Graft-Versus-Host Disease)
05/2016
1Infections
05/2016
1Distemper (Canine Distemper)
12/2010
1Hypersensitivity (Allergy)
05/2005
1Wounds and Injuries (Trauma)
01/2005
1Shock
01/2005
1Pulmonary Emphysema
05/2001
1Paraneoplastic Syndromes (Paraneoplastic Syndrome)
02/2001
1Carcinoma (Carcinomatosis)
06/2000
1Breast Neoplasms (Breast Cancer)
02/2000
1Squamous Cell Carcinoma (Epidermoid Carcinoma)
01/2000
1Pancreatic Neoplasms (Pancreatic Cancer)
01/2000
1Fibrosarcoma
01/2000

Drug/Important Bio-Agent (IBA)

3AntigensIBA
06/2000 - 01/2000
2AntibodiesIBA
12/2010 - 03/2001
2HLA-DRB1 Chains (HLA DRB1)IBA
05/2005 - 01/2000
2sulfoquinovosylacylglycerolIBA
01/2005 - 09/2004
2Retinaldehyde (Retinal)IBA
03/2001 - 02/2001
2RecoverinIBA
03/2001 - 02/2001
2EpitopesIBA
02/2001 - 01/2000
2Peptides (Polypeptides)IBA
06/2000 - 01/2000
2HLA-A31 antigenIBA
06/2000 - 01/2000
2peptide F4.2IBA
06/2000 - 01/2000
2Cancer VaccinesIBA
06/2000 - 01/2000
1Coloring Agents (Dyes)IBA
09/2016
1bisbenzimide ethoxide trihydrochloride (Hoechst 33342)IBA
09/2016
1CytokinesIBA
05/2016
1Pharmaceutical PreparationsIBA
09/2011
1Combined VaccinesIBA
12/2010
1Bacterial VaccinesIBA
12/2010
1HLA Antigens (Human Leukocyte Antigens)IBA
05/2005
1DiglyceridesIBA
09/2004
1sulfolipidsIBA
09/2004
1CalciumIBA
03/2001
1CaspasesIBA
03/2001
1AutoantigensIBA
03/2001
1Proteins (Proteins, Gene)FDA Link
03/2001
1HLA-A24 AntigenIBA
02/2001
1AutoantibodiesIBA
02/2001
1Interleukin-4 (Interleukin 4)IBA
06/2000
1Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA
06/2000
1Histocompatibility Antigens (Histocompatibility Antigen)IBA
06/2000
1Protein Subunit VaccinesIBA
06/2000
1Tryptophan (L-Tryptophan)FDA Link
02/2000
1T-Lymphocyte Epitopes (Epitopes, T Lymphocyte)IBA
01/2000

Therapy/Procedure

2Transplantation
05/2016 - 01/2005
1Liver Transplantation
09/2004
1Pneumonectomy (Lung Volume Reduction)
05/2001